[go: up one dir, main page]

FI813108A7 - -amylaasi-inaktivaattori, menetelmä sen valmistamiseksi, tähän inaktivaattoriin pohjautuva lääke sekä sen hyvähyväksikäyttö. - Google Patents

-amylaasi-inaktivaattori, menetelmä sen valmistamiseksi, tähän inaktivaattoriin pohjautuva lääke sekä sen hyvähyväksikäyttö.

Info

Publication number
FI813108A7
FI813108A7 FI813108A FI813108A FI813108A7 FI 813108 A7 FI813108 A7 FI 813108A7 FI 813108 A FI813108 A FI 813108A FI 813108 A FI813108 A FI 813108A FI 813108 A7 FI813108 A7 FI 813108A7
Authority
FI
Finland
Prior art keywords
inactivator
preparation
amylase
proper use
medicine based
Prior art date
Application number
FI813108A
Other languages
English (en)
Swedish (sv)
Other versions
FI813108L (fi
Inventor
Laszlo Vertesy
Miroslav Mracek
Gerhard Braunitzer
Heinz Aschauer
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19803038130 external-priority patent/DE3038130A1/de
Priority claimed from DE19813107106 external-priority patent/DE3107106A1/de
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of FI813108L publication Critical patent/FI813108L/fi
Publication of FI813108A7 publication Critical patent/FI813108A7/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/36—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Actinomyces; from Streptomyces (G)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465—Streptomyces
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/26—Containing cys-cys disulfide bridge between nonadjacent cysteine residues

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
FI813108A 1980-10-09 1981-10-07 -amylaasi-inaktivaattori, menetelmä sen valmistamiseksi, tähän inaktivaattoriin pohjautuva lääke sekä sen hyvähyväksikäyttö. FI813108A7 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19803038130 DE3038130A1 (de) 1980-10-09 1980-10-09 (alpha) -amylaseinaktivatoren sowie verfahren zu ihrer herstellung
DE19813107106 DE3107106A1 (de) 1981-02-26 1981-02-26 (alpha) -amylaseinaktivator und verfahren zu seiner herstellung

Publications (2)

Publication Number Publication Date
FI813108L FI813108L (fi) 1982-04-10
FI813108A7 true FI813108A7 (fi) 1982-04-10

Family

ID=25788382

Family Applications (1)

Application Number Title Priority Date Filing Date
FI813108A FI813108A7 (fi) 1980-10-09 1981-10-07 -amylaasi-inaktivaattori, menetelmä sen valmistamiseksi, tähän inaktivaattoriin pohjautuva lääke sekä sen hyvähyväksikäyttö.

Country Status (9)

Country Link
US (1) US4451455A (fi)
EP (1) EP0049847B1 (fi)
AU (1) AU542795B2 (fi)
CA (1) CA1172978A (fi)
DE (1) DE3169418D1 (fi)
DK (1) DK446481A (fi)
ES (1) ES505959A0 (fi)
FI (1) FI813108A7 (fi)
NO (1) NO813407L (fi)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5885899A (ja) * 1981-11-16 1983-05-23 Fujirebio Inc アミラ−ゼインヒビタ−およびその製造法
DE3331860A1 (de) * 1983-09-03 1985-03-21 Hoechst Ag, 6230 Frankfurt Verfahren zur herstellung von tendamistat
FI844289L (fi) * 1984-01-21 1985-07-22 Hoechst Ag Nya polypeptider med -amylashaemmande verkan, foerfarande foer deras framstaellning, deras anvaendning och farmaceutiska preparat.
DE3738541A1 (de) * 1987-11-13 1989-05-24 Hoechst Ag Verfahren zur isolierung und reinigung von hirudin
DE3536182A1 (de) * 1985-10-10 1987-04-16 Hoechst Ag Promotor-anordnung fuer streptomyceten-vektoren
WO1996012730A1 (en) * 1994-10-20 1996-05-02 Industrial Research Limited Separation of amino acids and peptides from protein hydrolysates
JP2007512359A (ja) 2003-11-19 2007-05-17 メタバシス・セラピューティクス・インコーポレイテッド 新規なリン含有甲状腺ホルモン様物質
US7262318B2 (en) * 2004-03-10 2007-08-28 Pfizer, Inc. Substituted heteroaryl- and phenylsulfamoyl compounds
US20050288340A1 (en) * 2004-06-29 2005-12-29 Pfizer Inc Substituted heteroaryl- and phenylsulfamoyl compounds
MX2007005137A (es) * 2004-11-23 2007-06-22 Warner Lambert Co Derivados del acido 7-(2h-pyrazol-3-il)-3, 5-dihidroxi-heptanoico como inhibidores de hmg co-a reductasa para el tratamiento de lipidemia.
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
WO2008070496A2 (en) 2006-12-01 2008-06-12 Bristol-Myers Squibb Company N- ( (3-benzyl) -2, 2- (bis-phenyl) -propan-1-amine derivatives as cetp inhibitors for the treatment of atherosclerosis and cardiovascular diseases
EP2170930B3 (en) 2007-06-04 2013-10-02 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
JP2011522828A (ja) 2008-06-04 2011-08-04 シナジー ファーマシューティカルズ インコーポレイテッド 胃腸障害、炎症、癌、およびその他の障害の治療のために有用なグアニル酸シクラーゼのアゴニスト
EP2321341B1 (en) 2008-07-16 2017-02-22 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
US20120046364A1 (en) 2009-02-10 2012-02-23 Metabasis Therapeutics, Inc. Novel Sulfonic Acid-Containing Thyromimetics, and Methods for Their Use
JP2013528172A (ja) 2010-05-21 2013-07-08 ファイザー・インク ２−フェニルベンゾイルアミド
US20130156720A1 (en) 2010-08-27 2013-06-20 Ironwood Pharmaceuticals, Inc. Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
US20130345392A1 (en) 2011-03-04 2013-12-26 Pfizer Inc Edn3-like peptides and uses thereof
WO2013133685A1 (en) 2012-03-09 2013-09-12 Biotropics Malaysia Berhad Extract formulations of rhodamnia cinerea and uses thereof
CA2905435A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
US9708367B2 (en) 2013-03-15 2017-07-18 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase and their uses
BR112015026513A2 (pt) 2013-04-17 2017-07-25 Pfizer derivados de n-piperidin-3-ilbenzamida para tratar as doenças cardiovasculares
RS65632B1 (sr) 2013-06-05 2024-07-31 Bausch Health Ireland Ltd Ultra-prečišćeni agonisti guanilat-ciklaze c, postupak njihove pripreme i upotrebe
CN113121450A (zh) 2014-08-29 2021-07-16 Tes制药有限责任公司 α-氨基-β-羧基粘康酸半醛脱羧酶抑制剂
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
US20180134667A1 (en) 2016-10-14 2018-05-17 TES Pharma S.r.I. Inhibitors of alpha-amino-beta-carboxymuconic acid semialdehyde decarboxylase
IL283182B2 (en) 2018-11-20 2025-10-01 Tes Pharma S R L Alpha-amino-beta-carboxymuconic acid semialdehyde decarboxylase inhibitors
MA54261B1 (fr) 2019-01-18 2025-03-28 Astrazeneca Ab Inhibiteurs de pcsk9 et leurs procédés d'utilisation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5125232B1 (fi) * 1965-02-24 1976-07-29
DE2701890C2 (de) * 1977-01-19 1983-08-04 Hoechst Ag, 6230 Frankfurt Peptielischer Glycosidhydrolase-Inhibitor aus einem Streptomyceten und seine Verwendung

Also Published As

Publication number Publication date
NO813407L (no) 1982-04-13
FI813108L (fi) 1982-04-10
EP0049847A2 (de) 1982-04-21
AU542795B2 (en) 1985-03-14
DE3169418D1 (en) 1985-04-25
EP0049847B1 (de) 1985-03-20
DK446481A (da) 1982-04-10
CA1172978A (en) 1984-08-21
ES8207217A1 (es) 1982-09-01
AU7615081A (en) 1982-04-22
US4451455A (en) 1984-05-29
ES505959A0 (es) 1982-09-01
EP0049847A3 (en) 1982-08-25

Similar Documents

Publication Publication Date Title
FI813108A7 (fi) -amylaasi-inaktivaattori, menetelmä sen valmistamiseksi, tähän inaktivaattoriin pohjautuva lääke sekä sen hyvähyväksikäyttö.
NO164837C (no) Acylfosfinoksyder, samt anvendelse derav.
NO153459C (no) Toeymykningspreparat, samt fremgangsmaate for fremstilling derav.
FI881985A7 (fi) Foerfarande foer framstaellning av terapeutiskt verkande (s,s,s)-isomerer av substituerade acylderivat av 1,2,3,4-tetrahydroisokinolin-3-karboxylsyror.
NO861445L (no) Naske-sikker kapsel, og fremgangsmaate og anordning for fremstilling av samme.
IT8022284A0 (it) N-aril-ossazolidinoni e -pirrolidinoni, e procedimenti per la loro preparazione.
NO160103C (no) Jodtyroninimmunogenkonjugat og jodtyroninderivat for fremstilling av jodtyroninimmunogenkonjugatet.
NO164506C (no) Strippemiddel og anvendelse derav.
NO156636C (no) Kirurgisk hefteapparat.
NL189716C (nl) Diorganopolysiloxanen en werkwijze ter bereiding daarvan.
FI833075A7 (fi) 2-nitro-1,1-eteenidiamiineja, menetelmiä niiden valmistamiseksi sekä niiden käyttö lääkeaineina.
FI823022A7 (fi) Amino-organoaminosilaanit, niiden valmistusmenetelmä ja niiden käyttö.
FI810907A7 (fi) Pysäytin köyttä varten, menetelmä sen valmistamiseksi sekä sen käyttö.
NO156513C (no) Kirurgisk hefteapparat.
FI822507A7 (fi) Tiivistysjärjestelmä, -laite, -menetelmä ja -tuote.
FI872598A7 (fi) N-1H-tetratsol-5-yyli-2-tofeeni-, N-1H-tetratsol-5-yyli-2-pyrroli- ja N-1H-tetratsol-5-yyli-2 -furaanikarboksamidit.
FI821480A7 (fi) Leikkausmenetelmä ja -laite.
FI823572A7 (fi) Plasmidi pAC 1, menetelmä sen valmistamiseksi ja sen käyttö.
NO875230D0 (no) Imidazolderivater, samt fremgangsmaater for fremstilling derav.
ES514892A0 (es) Un metodo para la preparacion de 2-hidroxi-aclacinomicinas a, b y n.
DE3761557D1 (de) Aufwindeverfahren, vorrichtung, produkt.
NO812115L (no) Fortilsetning, og fremgangsmaate for fremstilling derav.
NO880949D0 (no) Trykkformidlende, fluidumsisolerende tilpasningsanordning.
FI840207L (fi) Silplaot, skruvpress eller liknande.
NO152537C (no) Sageinnretning.

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: HOECHST AKTIENGESELLSCHAFT